As Charles River And WuXi PharmaTech Count Down To Shareholder Votes On Proposed Merger, Research Analysts Predict Defeat
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As Charles River Laboratories and WuXi PharmaTech count down toward crucial shareholder votes on Aug. 5 - on whether their proposed union should go forward or be shot down - the American and Chinese drug research outfits have issued a new call for ratification of the plan